MedTrace Logo

Timing of HCG Administration in IUI Cycles

NCT02330705 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 225

Last updated 2019-01-25

No results posted yet for this study

Summary

Evaluation of the effect of altering the timing of human chorionic gonadotropin (HCG) administration on the clinical pregnancy rate in intrauterine insemination (IUI) cycles.

Conditions

Interventions

DRUG

HCG

Women will be given HCG before IUI

Sponsors & Collaborators

  • Mohamed Ibrahem Eid

    lead OTHER

Principal Investigators

  • Mohamed I Eid, Dr · Mansoura University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2019-07-31
Completion
2019-08-31

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02330705 on ClinicalTrials.gov